Molecular genetic manipulation of mycobacteria would benefit from the isolation of mycobacterial genes that could serve both as genetic markers and as sequences used to target homologous integration of recombinant DNA into the genome. We isolated the Mycobacterium bovis BCG gene encoding orotidine-5'-monophosphate decarboxylase (OMP-DCase) by complementing an Escherichia coli mutant defective in this activity. The BCG OMP-DCase gene (uraA) The World Health Organization estimates that one in three humans is infected with Mycobacterium tuberculosis, the etiologic agent of tuberculosis (3, 27) . Over the past decade, there has been a recent resurgence in the incidence of tuberculosis in developed countries that has coincided with the AIDS epidemic (25). Because of their impact as major human pathogens and as a result of their profound immunostimulatory properties, mycobacteria have long been intensively studied. In the early 1900s, an attenuated mycobacterium, M. bovis bacille Calmette-Gu6rin (BCG), was isolated for use as a vaccine against tuberculosis (6, 7). Although the efficacy of this vaccine against tuberculosis varied considerably in different trials, and the reasons for its variable efficacy have yet to be resolved, BCG is among the most widely used human vaccines (10, 17) .
The World Health Organization estimates that one in three humans is infected with Mycobacterium tuberculosis, the etiologic agent of tuberculosis (3, 27) . Over the past decade, there has been a recent resurgence in the incidence of tuberculosis in developed countries that has coincided with the AIDS epidemic (25) . Because of their impact as major human pathogens and as a result of their profound immunostimulatory properties, mycobacteria have long been intensively studied. In the early 1900s, an attenuated mycobacterium, M. bovis bacille Calmette-Gu6rin (BCG), was isolated for use as a vaccine against tuberculosis (6, 7) . Although the efficacy of this vaccine against tuberculosis varied considerably in different trials, and the reasons for its variable efficacy have yet to be resolved, BCG is among the most widely used human vaccines (10, 17) .
The recent application of molecular biological technology to the study of mycobacteria has led to the identification of many of the major antigens that are targets of the immune response to infection by mycobacteria (14, 32, 34, 35) and to an improved understanding of the molecular mechanisms involved in resistance to antimycobacterial antibiotics (28, 37) . The development of tools that permit molecular genetic manipulation of mycobacteria has also allowed the construction of recombinant BCG vaccine vehicles (1, 8, 11, 12, 16, 18, 23, 24, 26, 31) . Genome mapping and sequencing projects are providing valuable information about the M. tuberculosis and M. leprae genomes that will facilitate further study of the biology of these pathogens (9, 33) .
Despite these advances, there are two serious limitations to our ability to manipulate these organisms genetically. (i) Very few mycobacterial genes that can be used as genetic markers have been isolated (8) 
(ii) Investigators have failed to obtain homologous recombination in slowly growing mycobacteria such as M. tuberculosis and M. bovis BCG (13, 33) , despite resuspended in 50 mM Tris (pH 8.0)-10 mM EDTA-10% sucrose-0.5 mg of lysozyme per ml and incubated at 37°C for 1 h. EDTA was then added to 1%, and the mixture was incubated at room temperature for 15 min. Three phenolchloroform extractions were performed and followed by RNase treatment, phenol-chloroform extraction, chloroform extraction, and ethanol precipitation. The DNA was then suspended in TE buffer (10 mM Tris [pH 7.5], 1 mM EDTA).
To construct the plasmid library, DNA was subjected to partial digestion with Sau3A and DNA fragments of 2 to 6 kb were isolated by agarose gel electrophoresis onto NA45 DEAE-paper and eluted in buffer containing 10 mM Tris HCl, 1 M NaCl, and 1 mM EDTA. The DNA fragments were then phenol-chloroform extracted, ethanol precipitated, and ligated into a BamHI-digested, calf intestinal phosphatase-treated pUC19 plasmid vector. E. coli cells were transformed with the ligated mixture, and approximately 4 x 105 recombinants were obtained. Plasmid DNA was obtained from the pool of transformed colonies by an alkaline lysis method.
The Agtll library was constructed by using a procedure described by Young et al. (36) . Briefly, BCG genomic DNA was subjected to random partial digestion with DNase (30) . Both DNA strands were sequenced by the dideoxy method (2) . Mycobacterial DNA has a high G+C content, and two different strategies were used to reduce band compression and other artifacts due to high G+C content. A subset of the reactions was carried out with Taq polymerase at a high temperature (70°C). In addition, dGTP and dITP were used in independent sequencing reactions (15) .
BCG transformation. BCG Pasteur (American Type Culture Collection) was grown in the log phase to an optical density at 600 nm of 0.5 in Middlebrook medium. BCG cells were harvested by centrifugation and washed twice with phosphate-buffered saline (PBS) and suspended in 1 mM MgCl (pH 7.2)-10% sucrose-15% glycerol at a concentration of 10 optical density units at 600 nm per ml. A 0.4-ml volume of BCG cells was mixed with 2 ,ug of plasmid DNA and electroporated in a 0.2-cm cuvette. Electroporation settings were 2.5 kV of potential and 25 ,uF of capacitance. After electroporation, cells were resuspended in 10 ml of Middlebrook medium and incubated at 37°C for 2 h before plating on Middlebrook agar containing 20 ,ug of kanamycin per ml.
Southern blot analysis. Genomic DNAs from BCG strains were isolated as described above, digested with restriction enzymes, subjected to agarose gel electrophoresis in the presence of ethidium bromide, transferred to nitrocellulose, and probed with DNA labelled with 32P by random priming, all by standard procedures (2) .
Nucleotide sequence accession number. The nucleotide sequence reported here has been provided to GenBank under accession number U01072.
RESULTS
Isolation of the BCG OMP-DCase gene by genetic complementation. The complementation strategy employed to isolate the BCG OMP-DCase gene was similar to that employed previously to isolate the homologous gene in M. smegmatis (11) . A recombinant library was constructed in E. coli vector pUC19 by using size-selected BCG genomic DNA fragments from a partial Sau3A digest. An E. coli pyrF mutant strain (Yl 107) was transformed with this library, and cells were plated on medium lacking uracil to select for uracil prototrophs and on rich medium containing ampicillin to ascertain the transformation frequency and estimate the fraction of transformants able to complement the E. coli pyrF defect. Approximately 0.05% of the cells transformed with the recombinant library became uracil prototrophs. DNA clones were obtained from six colonies able to grow in the absence of uracil, and restriction analysis revealed that these clones contained the same insert DNA. One of these clones, pY6006, was subjected to further study (Fig. 1) .
To identify the portion of the 3.5-kb insert DNA of pY6006 that was responsible for complementation, the 1.3-kb BamHI fragment of Tn9O3, which encodes aminoglycoside transferase (aph), was inserted into several different sites in pY6006 insert DNA, the resultant plasmids were reintroduced into the E. coli pyrF mutant strain, and the ability of the new plasmids to complement the mutant phenotype was assessed as before ( Fig. 1) . One of the three plasmids with insertion mutations, pY6006B, lost the ability to complement the pyrF mutant phenotype, suggesting that sequences necessary for the complementing activity are located in the vicinity of the BamHI site that is disrupted in pY6006B.
Analysis of DNA sequences for the left end of pY6006 insert DNA (as diagrammed in Fig. 1 (Fig. 4) . The predicted BCG protein is similar to a putative M. tuberculosis antigen encoded downstream of the gene for the 65-kDa antigen (22) and to an M. leprae antigen that may be an integral membrane protein (29) .
Southern analysis with whole genomic DNA revealed a single copy of the uraA gene and flanking DNA in the BCG genome (see below). The relative positions of the BCG uraA gene and the portions of other genes identified through sequence analysis are summarized graphically in Fig. 1 (13, 32) . It is possible that the efficiency of transformation has an influence on the ability to obtain homologous recombination. To maximize the transformation efficiency of BCG, we investigated the effect of adding glycine to the culture medium prior to harvesting cells for electroporation, as the presence of 1.5% glycine can affect the integrity of the cell wall and it seems to improve transformation efficiency in M. smegmatis (19) . In addition, we compared the efficiency of electroporation of BCG cells in water relative to that in buffer. Autonomously replicating plasmid pYUB12 (23) 
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Sequences of the BCG uraA locus and the predicted protein products. The DNA sequence was obtained from the same BCG DNA fragment used to generate pY6014 (Fig. 1) . Genes encoding OMP-DCase are widely used as genetic markers in diverse fungi, in slime molds, and in prokaryotes (4, 5, 15) . These genes are useful because they are nutritional markers and can permit the development of genetic systems that do not rely on drug resistance markers. Such systems may be advantageous where drug resistance is a concern in the manipulation of potential human pathogens. Genes encoding OMP-DCase are also useful as genetic markers because they allow the development of both positive and negative selection schemes (4, 15) . The facts that all organisms display the same basic UMP biosynthesis pathway, that all organisms examined have a single OMP-DCase gene, and that this gene can be readily cloned by complementation of E. coli pyrF mutants also contributed to our interest in the BCG OMP-DCase gene.
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We previously showed that integration of recombinant DNA molecules occurs predominantly at homologous loci in transformed M. smegmatis (11). The results described here indicate that integration of recombinant DNA molecules can occur at homologous sequences in transformed M. bovis BCG but more frequently occurs at nonhomologous loci. Other investigators have observed only illegitimate recombination events in an attempt to obtain homologous recombination in M. tuberculosis and M. bovis BCG (13) . There are several possibilities why this experiment failed to detect homologous recombination. One likely explanation is that the linearized DNA molecules used for transformation in this experiment contained a substantial amount of nonhomologous vector DNA at their ends; if the ends of DNA molecules are recombinogenic in slowly growing mycobacteria, as they are in other organisms, then the vector DNA may have directed recombination away from genomic sequences homologous to the incoming mycobacterial DNA. Another possible explanation is that integration into the met locus with the constructs used by Kalpana et al. (13) is lethal or that the met locus is a less favorable site for homologous recombination than uraA. It is also possible that the protocol described here for preparing BCG for transformation and for maximizing the efficiency of transformation produces cells that are more competent for homologous recombination.
Although gene replacement was not observed in the experiments described here, the ability to obtain single homologous recombination events should permit targeted gene disruption in slowly growing mycobacteria, as diagrammed in Fig. 6 . When the transforming DNA consists of an internal segment of a gene (lacking both ends of the functional gene) and marker DNA has been introduced into the center of this 
